Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Stat Rx USA
WARNING LETTER
•Stat Rx USA•February 15, 2012

Stat Rx USA – FDA Warning Letter, Feb 15, 2012

Record Details

The FDA issued a Warning Letter to Stat Rx USA, LLC, following a February 7-15, 2012, inspection of their pharmaceutical manufacturing facility. The inspection revealed significant violations of Current Good Manufacturing Practice (CGMP) regulations (21 C.F.R. Parts 210 and 211), rendering their drug products adulterated.

Key violations include: 1. **Failure to ensure returned drugs meet quality standards before redistribution (21 C.F.R. § 211.204):** The firm lacked adequate written procedures for evaluating returned drugs for quality, integrity, and exposure to adverse conditions or tampering. The provided draft SOP was insufficient, and the firm's response did not include the revised procedure. 2. **Lack of a written stability testing program (21 C.F.R. § 211.166(a)):** The firm did not have data or scientific evaluation to support the stability of repackaged products, particularly concerning the omission of desiccants present in original packaging and the assigned expiration dates. The firm's claim of being a "pharmaceutical tech" was rejected; they are considered a drug manufacturer subject to CGMP. 3. **Failure to retain appropriately identified reserve samples (21 C.F.R. § 211.170(b)):** Stat Rx USA did not retain reserve samples of repack

Company
Stat Rx USA
Inspection date
February 15, 2012
Product type
Drugs
Office
Department of Health and Human Services
People
  • John R. Gridley
  • Robert T. Ridge
View Company Profile

ID · 24d4eac1-f49a-4781-b342-fa02709aaafa

Violation Codes7
21 CFR 21021 CFR 21121 CFR 211.20421 CFR 211.166(a)21 CFR 211.170(b)FD&C Act 501(a)(2)(B)21 U.S.C. 351(a)(2)(B)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Stat Rx USA
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.